Dutasteride medical review in Spain
Dutasteride is licensed for benign prostate enlargement, not hair loss. Any off-label hair-loss discussion requires an individual doctor assessment, careful explanation of risks and alternatives, and never guarantees prescribing.
Book a doctor consultation first
The doctor confirms the indication, reviews symptoms, previous treatment, medicines, liver history, contraindications and whether examination, PSA interpretation or other monitoring is required.
Using dutasteride for hair loss is off-label. That must be discussed transparently and is not a routine or automatic route.
Repeat review only when unchanged
If another clinician has already established dutasteride at the same dose and there are no new problems, a repeat review may be suitable with named evidence showing your indication, medicine and dose.
New urinary symptoms, adverse effects, dose changes or missing evidence need a fuller doctor consultation.
Benign prostate enlargement
Dutasteride reduces dihydrotestosterone and is licensed for men with benign prostatic hyperplasia. The doctor may need to consider urinary symptoms, prostate assessment and PSA results in context.
Read the patient leaflet
The leaflet explains contraindications, pregnancy-handling precautions, interactions, possible adverse effects and correct capsule use.
Open the official dutasteride patient leaflet in a new tab ↗
How a Spanish e-prescription works
- Book the correct consultation or established-treatment review.
- Provide accurate medical details and evidence when using the repeat route.
- The doctor decides whether prescribing is safe, appropriate and legally permitted.
- If approved, a REMPe QR prescription is emailed for use at a participating Spanish pharmacy.
Common questions
Is dutasteride licensed for hair loss?
No. Its licensed indication is benign prostate enlargement. Hair-loss use is off-label and requires an individual medical decision.
Is a prescription guaranteed?
No. The clinician prescribes only when dutasteride is appropriate, safe and permitted.
Can stable treatment use the repeat service?
Potentially, when the indication, medicine and dose are established, unchanged and supported by suitable named evidence.
Can the dose or indication be changed through a repeat request?
No. A change in dose, indication or symptoms requires a fuller doctor consultation.
Dr Ben Harry Clegg
General practitioner · Málaga registration 292911940 · Nerja Medical Center NICA 55712
Clinical review date: 9 August 2026
Meet the telehealth medical team